VISCO360

Device Sight Sciences, Inc.
Total Payments
$44,923
Transactions
57
Doctors
41
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $44,923 57 41

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,213 7 47.2%
Travel and Lodging $9,008 1 20.1%
Current or prospective ownership or investment interest $6,570 3 14.6%
Unspecified $6,000 1 13.4%
Food and Beverage $2,132 45 4.7%

Payments by Type

General
$38,923
56 transactions
Research
$6,000
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma Sight Sciences, Inc. $6,000 0

Top Doctors Receiving Payments for VISCO360 — Page 2

Doctor Specialty Location Total Records
, M.D Ophthalmology Philadelphia, PA $31.41 1
, M.D Ophthalmology Chicago, IL $29.83 1
, MD Ophthalmology Tacoma, WA $28.15 1
, M.D Ophthalmology Springdale, AR $28.11 1
, MD, PHD Ophthalmology Portland, OR $23.25 1
, OD Corneal and Contact Management Phoenix, AZ $20.78 1
Matthew Niemeyer Seattle, WA $20.30 1
, M.D Ophthalmology Bend, OR $18.75 1
, MD Ophthalmology Norfolk, VA $16.28 1
, MD Ophthalmology Pine Bluff, AR $15.50 1
, M.D Ophthalmology Houston, TX $15.46 1
, M.D Ophthalmology Bloomington, MN $15.10 1
, M.D Ophthalmology Seattle, WA $14.66 1
, MD Ophthalmology Atlanta, GA $13.69 1
, MD Ophthalmology Sioux Falls, SD $13.01 1
, OD Optometrist San Mateo, CA $4.57 1
, O.D Optometrist San Mateo, CA $4.57 1

About VISCO360

VISCO360 is a device associated with $44,923 in payments to 41 healthcare providers, recorded across 57 transactions in the CMS Open Payments database. The primary manufacturer is Sight Sciences, Inc..

Payment data is available from 2017 to 2017. In 2017, $44,923 was paid across 57 transactions to 41 doctors.

The most common payment nature for VISCO360 is "Consulting Fee" ($21,213, 47.2% of total).

VISCO360 is associated with 1 research study, including "Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma" ($6,000).